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Abstract 
BACKGROUND: Cerebral microangiopathy is one of the most important complications in diabetes. It may interfere with 
cerebral vasomotor reactivity (VMR) which may lead to disability, stroke or even death. The aim of the pr sent study 
was to determine and compare VMR changes in diabetic and non-diabetic patients. 
METHODS:  Fifty three diabetic and 51 non-diabetic patients (with no other vascular abnormality) were recruited. Vaso-
motor reactivity was evaluated with Trans-Cranial Doppler (TCD) before and after CO2 inhalation. 
RESULTS: There were 69 (66.30%) males. The mean age was 41.53 ± 17.80 years. The general average of VMR was 
5.79 ± 3.00%, the figures in diabetic and nondiabetic patients were 5.31 ± 2.60% and 6.62 ± 2.00%, respectively (p = 
0.02). The average of flow velocity (FV) change was 42.47± 29.00 in diabetics and 53.34 ±16.70 in non-diabetic pa-
tients (p = 0.04). 
CONCLUSIONS: It is recommended that such non-invasive method is necessary for evaluation of cerebral vasculature in 
diabetic patients for better prevention. 
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ranscranial Doppler (TCD) ultrasono-
graphy is a safe, noninvasive, and low-
cost technique which neurologists utilize 
it for imaging the large intracranial vessels at 
the skull base.1 This technique, which became 
available in 1982, enables assessment of hemo-
dynamic parameters including flow velocity in 
intracranial arteries.2 The ability of the flow 
velocity to adapt to stimuli like hypercapnia is 
called vasomotor reactivity (VMR), which is 
another hemodynamic parameter.3 
 Cerebral blood flow is regulated by chang-
ing in arterioles resistance,4,5 i.e. with their 
dilatation and constriction. A profound de-
crease in cerebral perfusion may lead to ische-
mia and the vasomotor reactivity will abolish
when the cerebral vessels get their maximum 
dilatation,6,7 indeed the vessels don’t respond 
to any vasodilator stimulant even to hyper-
capnia which is the most powerful stimulant.8,9 
 Diabetes is one of the well known risk factor 
for cerebrovascular accident (CVA).4,10 Pro-
longed untreated diabetes mellitus leads to mi-
croangiopathy, tissue hypoxia and ischemic 
lesions; it increases the risk for stroke and ex-
acerbates brain tissue damage following 
ischemia.10,11 Its prevalence in diabetic patients 
is 2-6 times more than non-diabetics 12-14 and 
eventually its complications and subsequent 
morbidity is higher, too. Patients exhibit ad-
vanced atherosclerosis in coronary and cere-
bral arteries as well as enhanced vascular
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responsiveness to vasoconstrictors, an attenu-
ated response to vasodilators and impaired 
autoregulation of cerebral blood flow. Altered 
endothelial function of arterioles and an im-
paired vasomotor function of resistance vessels 
can contribute to altered regulation of regional 
blood flow and insufficient tissue perfusion in 
diabetes mellitus.10,11 Therefore, early diagnosis 
and treatment of vascular complications may 
lead to better care of diabetic patients and pre-
vent consequent complications.8,9,12 
 TCD and VMR provide non-invasive and 
easy methods in predicting high risk patients 
for cerebrovascular accident,11 particularly to 
lessen the mortality and morbidity rate at least 
in the elective situations and predictable 
stresses such as surgery and other medical ill-
nesses.4,13 
 The current study is conducted to deter-




A cross-sectional study was conducted at a re-
ferral hospital affiliated to the Iran University 
of Medical Sciences (IUMS). Fifty-three pa-
tients with definite diagnosis of diabetes melli-
tus (NIDDM) who referred to endocrinology 
clinic were enrolled.  
 Controls were 51 participants selected from 
those who visited the orthopedic minor trauma 
outpatient clinic of the same hospital or per-
sons accompanying patients who admitted to 
the neurology ward. Selection of both cases 
and controls was done by an investigator (as-
sistant of neurology). All participants (both 
patients and controls) underwent TCD by one 
neurologist who was unaware of their status. 
 Non-cooperative cases and controls and 
those with a history of cerebrovascular dis-
eases, coronary artery disease, hypertention, 
any vasculitis, anatomic abnormality of middle 
cerebral artery and poor window in TCD were 
excluded from the study. 
 The Medical Ethics Committee of IUMS ap-
proved the study. Written informed consent as 
obtained from all cases and controls before 
participation in the study. 
 
Transcranial Doppler 
This study was performed (with Explorer-CVS, 
DMS, France, Probe 2 MHz) to measure the 
cerebral blood flow velocity in the middle 
cerebral artery on both sides. End diastolic, 
peak systolic, and mean cerebral blood flow 
velocities were recorded automatically. After 
the finding of middle cerebral artery (MCA), 
the cerebrovascular CO2 reactivity measure-
ment was performed as follows: the cerebral 
blood flow velocity was measured continu-
ously and the participants first breathed room 
air through an anesthetic mask. Participants 
were then asked to inhale a mixture of 5% car-
bon dioxide in 95% oxygen for 2 minutes. The 
blood velocity of MCA is expected to increase 
after 20-30 seconds. The flow velocity (FV) in-
dices were recorded if there was no increasing 
in the velocity. 
 The cerebral VMR was determined accord-




To compare the average of FV and VMR be-
tween the two groups independent t-test was 
utilized. A p value of < 0.05 was considered 
significant. All calculations were performed 
with the SPSS version 13.0 for Windows (SPSS 
Inc., Chicago, Illinois, USA). 
Results 
All of 104 participants in this study were 
evaluated. There were 69 (66.30%) males and 
35 females. The mean age (± SD) was 41.53 ± 
17.80 years. The average of flow velocity (FV) 
changes in general was 47.80 ± 24.35 cm/s. In 
diabetic and non-diabetic patients the average 
FV were 42.47 ± 29.00 cm/s and 53.34 ± 16.70 
cm/s, respectively (p = 0.04). The general av-
erage of VMR was 5.79 ± 3.00%. The figures in 
diabetic and nondiabetic patients were  
5.31 ± 2.60% and 6.62 ± 2.00%, respectively  
(p = 0.02). The range of VMR in diabetic and 
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nondiabetic cases was 1.71-8.91% and 4.61-
8.66%, respectively. The average FV and VMR  
was compared between the two groups regard-
ing age and it showed significant differences (p 
= 0.009). However, there was no statistical sig-
nificance regarding sex (p = 0.06). The findings 
are summarized in tables 1 and 2. 
 
Table 1. The average VMR in participants  
regarding to gender 
 Gender Number VMR (SD) (%) 
M 21 5.80 (3.70) Diabetic 
F 32 4.95 (3.50) 
M 48 6.58 (2.00) Non-
diabetic F 3 7.94 (2.20) 
M 69 6.36 (2.60) Total 
F 35 5.20 (3.50) 
VMR: vasomotor reactivity; M: male; F: female 
 
Table 2. The average VMR and FV in diabetic and non-diabetic patients 
VMR FV (SD) (cm/s)  
Average (SD) Range P value Average (SD) Range P value 
Diabetic 5.31 (2.60) 5.31 ± 2.60 42.47 (29.07) 42.27 ± 29.00 
Non-diabetic 6.62 (2.00) 6.62 ± 2.00 
0.02 
53.34 (16.70) 53.34 ± 16.70 
0.04 
Total  5.79 (3.00) 5.79 ± 3.00 - 47.80 (24.35) 47.80 ± 24.35 - 
FV: flow velocity (cm/s) 
 
Discussion 
Cerebrovascular reactivity is a hemodynamic 
parameter representing the increase in normal 
cerebral artery blood flow in response to a 
vasodilator stimulus such as hypercap-
nia.3,4,7,8,12,14 An early preclinical detection of 
cerebrovascular complications in individuals 
with diabetes is one of the goals in health care.9 
In this study the VMR or cerebral vessels re-
serve was evaluated. The difference between 
minimum and maximum of cerebral arteries 
diameter demonstrates the cerebral reserve 
and the more the difference, the more the re-
serve.3 The importance of such a reserve will 
be elucidated by the fact that whenever brain 
encounters any stress, it increases its blood 
volume in defiance of it, so more increase in 
blood flow would be more effective against 
stresses, although it depends on many factors 
such as age, gender, systemic hypertension 
and other vascular diseases. It is estimated that 
diabetes may reduce the cerebral reserve by 
the affect on the elasticity of the vessels.7,8,12 It 
was found in the present study that the aver-
age of VMR was 5.31 ± 2.60% in diabetics and 
6.62 ± 2.00% in nondiabetic patients (p = 0.022). 
The present findings are compatible with a 
study conducted in Debercen University, 
Hungary, showing a significant difference be-
tween VMR in diabetic and nondiabetic pa-
tients.9 Also, a study performed by Lipsitz et al 
showed that cerebrovascular reactivity was 
impaired in normotensive NIDDM patients.14 
In the present study, it was found that sex may 
be a factor affecting VMR, which is consistent 
with previous study.9 
Conclusions 
The present results indicate that diabetes may 
decrease the brain blood flow reserve inde-
pendent to age that may go along with an in-
creasing risk for vascular events, although it 
still remains unknown if the duration of diabe-
tes will enhance this deleterious effect. To elu-
cidate the effect of sex, further studies with 
more patients may be needed. 
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